More than two-thirds of people in the U.S. who know about RSV said they're worri...
Hundreds of GSK workers have voted to stage a series of walkouts at U.K. manufac...
A drug by Relay Therapeutics shows it can attack breast cancer cells without cau...
The CAR-T cancer therapy called Carvykti reduced the risk of relapse by 74% comp...
After Vivian Cheung developed a genetic condition that caused her to start losin...
A STAT investigation of private equity-owned Mindpath Health uncovered a range o...
Regulators are considering two highly effective RSV vaccines. What's the holdup?
Look to tulip production in the Netherlands for a cautionary tale on the overuse...
In its latest bid to upend the pharmaceutical supply chain, the Mark Cuban Cost ...
A new kind of chemistry, which won the Nobel Prize, gets its first test as a pos...
People ages 65 and older and those who are immunocompromised will be allowed to ...
Realizing the benefits of animals with intentional genomic alterations depends o...
For Sarepta, an experimental gene therapy is a story of foresight, savvy dealmak...
New results involving a Moderna-Merck mRNA vaccine provides the strongest confir...
For Merck, acquiring Prometheus bolsters its research pipeline and introduces ne...
Access to the abortion pill mifepristone will remain unchanged until next Wednes...
